Associate Epidemiologist, Department of Medicine
Brigham and Women's Hospital

joel@envsparc.harvard.edu

My research is divided in three main areas: First, I am interested in epidemiology looking at the health consequences of exposure to pollutants. To date this has had two focuses: health effects of lead and health effects of air pollutants. I have recently begun work looking at water contamination. In lead, I have examined cardiovascular effects of lead exposure in adults, cognitive effects in children, auditory effects in children, and effects of lead on children's growth. I have also done work on sources of lead exposure, including establishing gasoline lead as the major source of lead exposure in the United States. My air pollution work has examined both acute and chronic effects of air pollution exposure. Recent research has established that exposure to fine combustion particles in the air at concentrations well below current standards are associated with a range of adverse health effects from increased respiratory symptoms, to increased hospital admissions, to increased deaths. This work has led to a tightening of the US air quality standards. I have also done considerable work on health effects of ozone exposure. I have several international collaborations underway in this area.

I am also interested in methodological questions regarding the modeling of continuous covariates in epidemiologic studies, both for better covariate control and to more accurately assess the relationship between exposure and response. This has involved regression spline models, nonparametric smoothing, and generalized additive models. I have demonstrated the effectiveness of these tools in applications in both lead and air pollution studies. I have also been interested in issues involving time series studies, where the outcomes measures are not independent. This has involved generalized least squares and generalized estimating equation approaches.

A third major focus of my research is on the effects of antioxidants on respiratory health. To data this has focused on chronic effects (e.g. relationship between dietary intake and level of pulmonary function or symptoms), but future research will examine their potential to modify acute responses as well.

A final area of interest is in the use of cost benefit analysis to make environmental decisions. I have developed benefit methodologies for assessing the benefits of lead control, and applied those methodologies to the decision to remove lead from gasoline, and recently, in collaboration with colleagues at the Centers for Disease Control, to a decision to revise their screening recommendations for children. I am also involved in cost benefit analysis of air pollution control.

Pirkle J, Schwartz J, Landis R, Harlin W. The relationship between blood lead levels and blood pressure and its cardiovascular risk implications. Am J Epidemiol. 1985 Feb;121(2):246-58. [abstract]

Schwartz J, Weiss ST. Relationship between dietary vitamin C intake and pulmonary function in the First National Health and Nutrition Examination Survey (NHANES I). Am J Clin Nutr. 1994 Jan;59(1):110-4. [abstract]

Schwartz J. Societal benefits of reducing lead exposure. Environ Res. 1994 Jul;66(1):105-24. [abstract]

Schwartz J. Nonparametric smoothing in the analysis of air pollution and respiratory disease. Canadian J Stat, 1994, 22:471-87. No abstract available.

Schwartz J, Dockery DW, Neas LM. Is daily mortality associated specifically with fine particles? J Air Waste Manag Assoc. 1996 Oct;46(10):927-39. [abstract]